Inhibition of xenogeneic GVHD by PEN110 treatment of donor human PBMNCs.
D000818:Animals; D000910:Antibodies, Heterophile; D004195:Disease Models, Animal; D017707:Erythrocyte Transfusion / Q000009:adverse effects*; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007962:Leukocytes / Q000276:immunology*; D051379:Mice; D016513:Mice, SCID; D011073:Polyamines / Q000494:pharmacology*
D000910:Antibodies, Heterophile; C451719:PEN 110; D011073:Polyamines